Emcure Pharmaceuticals' Kadu unit clears USFDA inspection
Emcure Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) had conducted surveillance inspection of Company's manufacturing facility located at Survey No. 485 (New), 160/P1 (Old), Kadu, Taluka - Lakhtar, District- Surendranagar, Gujarat - 382775, from 06 October 2025 to 10 October 2025. The inspection is concluded without any observation.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 10 2025 | 2:43 PM IST